Medicines consultations

We also consult on valid applications to change the legal status (prescription only, pharmacy or general sale list) of medicines; these consultations are given the prefix, 'ARM' (applications to reclassify medicines).  At the end of the exercise copies of all non-confidential replies can be requested from our Information Centre, e-mail info@mhra.gsi.gov.uk.

Medicines consultations

• 16 Oct 2008| Public consultation ARM 55: Request to reclassify Ultra Chloraseptic Spray from Pharmacy (P) to General Sale List (GSL) - Reminder that the deadline for comments is 13 November 2008

  Consultation ARM 55 seeks your views on the reclassification from P to GSL of Ultra Chloraseptic Spray.

• 15 Oct 2008| Public consultation (MLX 354): MHRA regulatory fees for medicines - proposals for 1 April 2009

  MLX 354 seeks your views on proposals to change the levels of fees charged by the MHRA for the regulation of medicines, including herbal and homoeopathic medicines, and blood establishments and blood banks.

• 01 Oct 2008| Public consultation ARM 60: Request to reclassify Hedrin 4% lotion - Reminder that the deadline for comments is 29 October 2008

  Consultation ARM 60 seeks your views on the reclassification from P to GSL of Hedrin® 4% Lotion.

• 01 Oct 2008| Public consultation ARM 59: Request to reclassify Bazuka treatment gel from Pharmacy (P) to General Sales List (GSL)

  Consultation ARM 59 seeks your views on the reclassification from P to GSL of Bazuka Treatment Gel.

• 01 Oct 2008| Public consultation ARM 58: Request to reclassify Nicorette nasal spray from Pharmacy (P) to General Sales List (GSL)

  Consultation ARM 58 seeks your views on the reclassification from P to GSL of Nicorette Nasal Spray.

• 01 Oct 2008| Public consultation ARM 57: Request to reclassify Freederm Gel from Pharmacy (P) to General Sales List (GSL)

  Consultation ARM 57 seeks your views on the reclassification from P to GSL of Freederm Gel.

• 09 Sep 2008| Discussion about the management of withdrawal from Seroxat (Paroxetine) and other Selective Serotonin Reuptake Inhibitors (SSRIs)

  A meeting has been held with Bob Fiddaman, campaigner and author of the Seroxat Sufferers blog, to discuss withdrawal issues.

• 29 Aug 2008| Public consultation (MLX 351): Proposals for amendments to medicines legislation to allow dispensing opticians access to certain prescription only medicines (poms)

  MLX 351 seeks your views on proposals for amendments to medicines legislation to allow dispensing opticians access to certain prescription only medicines (POMs).

• 31 Jul 2008| Public consultation ARM 54: Request to reclassify a bottle presentation of Calpol Six Plus Suspension Sugar Free from Pharmacy (P) to General Sales List (GSL)

  Reminder: Closing date for comments is 6 August 2008.
  ARM 54 seeks your views on the reclassification from P to GSL of a bottle presentation of Calpol Six Plus Suspension Sugar Free.

• 23 Jul 2008| Public consultation (MLX 353): Consultation on advanced therapy medicinal products

  This consultation seeks your views on proposals for the UK’s exemption scheme for advanced therapy medicinal products (ATMPs) under Article 28 (2) of Regulation EC No 1394/2007 (“the ATMP Regulation”).